New treatment option for Functional Gastrointestinal Disorders (FGIDs)
Official title Mechanism of FODMAP Restriction on FGID Patients
ClinicalTrials.gov ID: NCT07000227
What this study is testing
- What it's testing
- Brief Summary : The goal of this clinical trial is to investigate the effects of differing FODMAP diets on gut microbiota, gut barrier function, symptom severity, quality of life, and psychological status in FGID patients. The main question it aims to answer is : How does diets with differing FODMAP content affect the gut microbiota, gut barrier function, symptom severity, psychological status and quality of life in patients with FGID ?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged 18 and above
- Able to provide informed consent
- Those with pre-existing irritable bowel syndrome (IBS) or functional dyspepsia (FD) or both screened by gastroenterologists
- Meet the ROME III- Asian criteria for FGID
- Able to communicate in Malay or English language
You likely can't join if
- Pregnant or lactating women
- History declared by the participant of pre-existing gastrointestinal disorder, including but not limited to Inflammatory Bowel Disease, Coeliac...
- Cancer of any kind
- Patients with reported history of previous resection of any part of the GI tract other than appendix or gall bladder, intestinal stoma
- Habitual use of opiate analgesics likely to alter bowel function e.g. morphine
- Use of antibiotics in the preceding two weeks and/or in the past one month
See the full eligibility criteria
- Aged 18 and above
- Able to provide informed consent
- Those with pre-existing irritable bowel syndrome (IBS) or functional dyspepsia (FD) or both screened by gastroenterologists
- Meet the ROME III- Asian criteria for FGID
- Able to communicate in Malay or English language
- Pregnant or lactating women
- History declared by the participant of pre-existing gastrointestinal disorder, including but not limited to Inflammatory Bowel Disease, Coeliac Disease, Pancreatitis, Gallstone disease (biliary colic, cholecystitis)...
- Cancer of any kind
- Patients with reported history of previous resection of any part of the GI tract other than appendix or gall bladder, intestinal stoma
- Habitual use of opiate analgesics likely to alter bowel function e.g. morphine
- Use of antibiotics in the preceding two weeks and/or in the past one month
- Consumption of probiotics, prebiotics or fibre supplements in the past one month
- Enteral feeding or texture modified diet patients
- Those with cognitive impairment or severe mental disorder (Alzheimer's, schizophrenia, bipolar disorder. etc)
- Shift workers (e.g. Nurse, doctors)
The study team makes the final eligibility decision.
Where it's taking place
- Kuala Lumpur, Kuala Lumpur, Malaysia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kuala Lumpur, Kuala Lumpur, Malaysia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.